Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
AOD-9604 produces fat loss without any tissue growth effects
The compound was developed by the Australian biotech firm Metabolic Pharmaceuticals as a research tool to isolate the lipolytic signaling domain of growth hormone without the receptor-binding region responsible for its anabolic and glucose-handling effects
That means faster, more reliable absorption than oral supplements
Rated 3 out of 5 Anonymous It burns every time I inject and makes the muscle tender for an extended period
Accredited Fields: HPLC, GC-FID, GC-MS, ICP-MS, LC-MS/MS, Karl Fischer Titration, Polarimetry, UV-Vis Spectrophotometry, FT-IR, Bacterial Endotoxin Testing (LAL), Sterility Testing, Microbial Limits, Particle Size Analysis (Laser Diffraction), DSC/TGA Thermal Analysis Accreditation Date:2023-09-01 Valid Until:2027-08-31 CNAS : CNAS-A3374 NMPA National Medical Products Administration (NMPA) Drug Manufacturing License License No.: 1756142024143 : : : : 572120 : Scope: APIs (Chemically Synthesized Peptides, Chemical APIs), Pharmaceutical Excipients Issue Date:2024-01-10 Valid Until:2029-01-09 : Certificate Verification Scan QR code or visit SHA-256: b2aa807ca89b02f5
US$ 21.81
US$ 25.72
US$ 24.48
US$ 23.16
US$ 20.06
US$ 20.44
)
